U.S. FDA to reconsider decision barring compounded versions of Lilly weight loss drug

[ad_1]

The agency said it would now allow compounding pharmacies and facilities to provide the drugs while it reviews if there is a shortage of their active ingredient.

[ad_2]

Source link